michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PCOS, independent <strong>of</strong> BMI that decrease with metformin treatment. 5 The pathophysiology <strong>of</strong> PCOS<br />
has been elegantly reviewed. 3<br />
PCOS has not been specifically linked to adverse cardiovascular outcomes, per se.<br />
Nevertheless, women with PCOS manifest several high risk markers for future cardiovascular disease<br />
including: 1) an atherogenic lipid pr<strong>of</strong>ile, 2) elevated c-reactive protein, 3) leucocytosis, 4) levels, 5)<br />
increased endothelin, 6) raised insulin levels, 7) left ventricular hypertrophy, 8) diastolic dysfunction, 9)<br />
increased coronary calcification and endothelial dysfunction, and 10) elevated plasminogen activator<br />
inhibitor (PA-I) levels.<br />
In summary, PCOS is common and under-diagnosed; once diagnosed, the patient must be<br />
screened for hyperlipidemia, obstructive sleep apnea and masked <strong>hypertension</strong> preferably with 24 hour<br />
ambulatory blood pressure monitoring. Additional features <strong>of</strong> PCOS such as infertility and increased<br />
risk <strong>of</strong> endometrial cancer must be co-managed with the patients’ gynecologist. Treatment consists <strong>of</strong><br />
weight loss, exercise and insulin sensitizing agents such as metformin, which may also restore fertility,<br />
and comprehensive CVD risk factor management including control <strong>of</strong> BP.<br />
References:<br />
1. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and<br />
glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:36-42.<br />
2. Tasali E, Van Cauter E, H<strong>of</strong>fman L, Ehrmann DA. Impact <strong>of</strong> obstructive sleep apnea on insulin<br />
resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab<br />
2008;93:3878-84.<br />
3. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.<br />
4. Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS. Relationship between androgen<br />
levels and blood pressure in young women with polycystic ovary syndrome. Hypertension<br />
2007;49:1442-7.<br />
5. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence <strong>of</strong><br />
obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol<br />
Metab 2001;86:1175-80.<br />
NKFM & MDCH 97